Factors associated to COVID-19 vaccine acceptance in Mexican patients with rheumatic diseases: A cross-sectional and multicenter study

References

• Sparks JA, Wallace ZS, Robinson PC. Coronavirus disease 2019: update on coronavirus disease 2019 outcomes and vaccine efficacy in patients with immune-mediated inflammatory disease. Curr Opin Rheumatol. 2021;33:412–10. doi:10.1097/BOR.0000000000000812.
   PubMed Web of Science ®Google Scholar
• Curtis JR, Johnson SR, Anthony DD, Arasaratnam RJ, Baden LR, Bass AR, et al. American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases – version 5. Recommendations updated February 2, 2022 [accessed 2022 March 11]. https://www.rheumatology.org/Portals/0/Files/COVID-19-Vaccine-Clinical-Guidance-Rheumatic-Diseases-Summary.pdf
   Google Scholar
• Li X, Tong X, Yeung WWY, et al. Two-Dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong KongAnn Rheum Dis. 2022;81:564-68.
   Web of Science ®Google Scholar
• Sattui SE, Liew JW, Kennedy K, Sirotich E, Putman M, Moni TT, Akpabio A, Alpízar-Rodríguez D, Berenbaum F, Bulina I, et al. Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 global rheumatology alliance vaccine survey. RMD Open. 2021;7:e001814. doi:10.1136/rmdopen-2021-001814.
   PubMed Web of Science ®Google Scholar
• Boekel L, Hooijberg F, van Kempen ZLE, Vogelzang EH, Tas SW, Killestein J, Nurmohamed MT, Boers M, Kuijpers TW, van Ham SM, et al. Perspective of patients with autoimmune diseases on COVID-19 vaccination. Lancet Rheumatol. 2021;3:e241–43. doi:10.1016/S2665-9913(21)00037-0.
   PubMedGoogle Scholar
• Felten R, Dubois M, Ugarte-Gil MF, Chaudier A, Kawka L, Bergier H, Costecalde C, Pijnenburg L, Fort J, Chatelus E, et al. Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases. Lancet Rheumatol. 2021;3:e243–45. doi:10.1016/S2665-9913(21)00039-4.
   PubMedGoogle Scholar
• Priori R, Pellegrino G, Colafrancesco S, Alessandri C, Ceccarelli F, Di Franco M, Riccieri V, Scrivo R, Sili Scavalli A, Spinelli FR, et al. SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists. Ann Rheum Dis. 2021;80:953–54. doi:10.1136/annrheumdis-2021-220059.
   PubMed Web of Science ®Google Scholar
• Yurttas B, Poyraz BC, Sut N, Ozdede A, Oztas M, Uğurlu S, Tabak F, Hamuryudan V, Seyahi E. Willingness to get the COVID-19 vaccine among patients with rheumatic diseases, healthcare workers and general population in Turkey: a web-based survey. Rheumatol Int. 2021;41:1105–14. doi:10.1007/s00296-021-04841-3.
   PubMed Web of Science ®Google Scholar
• Smerilli G, Cipolletta E, Moscioni E, Francioso F, Risa AM, Maccarrone V, Zompa D, Di Matteo A, Di Carlo M, De Angelis R, et al. Correspondence on ‘SARS-CoV-2 vaccine hesitancy among patients with rheumatic and musculoskeletal diseases: a message for rheumatologists’. Ann Rheum Dis. 2021;80:e168. doi:10.1136/annrheumdis-2021-220586.
   PubMed Web of Science ®Google Scholar
• Gaur P, Agrawat H, Shukla A. COVID‑19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview‑based survey. Rheumatol Int. 2021;41:1601–05. doi:10.1007/s00296-021-04938-9.
   PubMed Web of Science ®Google Scholar
• Campochiaro C, Trignani G, Tomelleri A, Cascinu S, Dagna L, COVID-19 Vaccine Study Group .Potential acceptance of COVID-19 vaccine in rheumatological patients: a monocentric comparative survey. Ann Rheum Dis. 2021;80:816–17. annrheumdis-2020-219811. doi:10.1136/annrheumdis-2020-219811.
   PubMed Web of Science ®Google Scholar
• Bugatti S, Balduzzi S, De Stefano L, Manzo A, Xoxi B, Bogliolo L, Monti S, Delvino P, Montecucco C. Correspondence on ‘EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs’. Ann Rheum Dis. 2021;80:e156. annrheumdis-2021-220541. doi:10.1136/annrheumdis-2021-220541.
   PubMed Web of Science ®Google Scholar
• Ko T, Dendle C, Woolley I, et al. SARS-COV-2 vaccine acceptance in patients with rheumatic diseases: a cross-sectional study. Hum Vaccin Immunother. 2021;17:4048-56. doi:10.1080/21645515.2021.1958611
   Google Scholar
• MacDonald NE, . SAGE Working Group on Vaccine Hesitancy .Vaccine hesitancy: Definition, scope and determinants. Vaccine. 2015;33:4161–64. doi:10.1016/j.vaccine.2015.04.036.
   PubMed Web of Science ®Google Scholar
• Esquivel-Valerio JA, Skinner-Taylor CM, Moreno-Arquieta IA, Cardenas-de la Garza JA, Garcia-Arellano G, Gonzalez-Garcia PL, Almaraz-Juarez FDR, Galarza-Delgado DA. Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study. Rheumatol Int. 2021 ;41(12):2105–08. doi:10.1007/s00296-021-05017-9.
   PubMed Web of Science ®Google Scholar
• Furer V, Rondaan C, Agmon-Levin N, van Assen S, Bijl M, Kapetanovic MC, de Thurah A, Mueller-Ladner U, Paran D, Schreiber K, et al. Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases. RMD Open. 2021;7:e001594. doi:10.1136/rmdopen-2021-001594.
   PubMed Web of Science ®Google Scholar
• Cucciniello M, Pin P, Imre B, Porumbescu GA, Melegaro A. Altruism and vaccination intentions: Evidence from behavioral experiments [published online ahead of print, 2021 Jul 13]. Soc Sci Med. 2021;292:114195. doi:10.1016/j.socscimed.2021.114195.
   PubMed Web of Science ®Google Scholar
• Batson CD, Lishner DA, Stocks EL. The empathy—altruism hypothesis. In: Schroeder DA, Graziano WG editors. Oxford Library of psychology. The Oxford handbook of prosocial behavior. Oxford University Press; 2015. pp. 259–81.
   Google Scholar
• Rogers W, Ballantyne A. Special populations: vulnerability and protection. RECIIS Electronic J Commun Inf Innovation Health. 2008;2(Suppl 1):S30-S40.
   Google Scholar
• Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, Syunyaev G, Malik AA, Aboutajdine S, Adeojo O, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27:1385–94. doi:10.1038/s41591-021-01454-y.
   PubMed Web of Science ®Google Scholar
• Guaracha-Basáñez G, Contreras-Yáñez, Álvarez-Hernández E, et al. COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases. Human Vacc Immunother 2022 17(12). Accepted for publication. doi:10.1080/21645515.2021.2003649
   Google Scholar
• England BR, Sayles H, Mikuls TR, Johnson DS, Michaud K. Validation of the rheumatic disease comorbidity index. Arthritis Care Res (Hoboken). 2015;67:865–72. doi:10.1002/acr.22456.
   PubMed Web of Science ®Google Scholar
• Schmid P, Rauber D, Betsch, et al. Barriers of influenza vaccination intention and behavior – a systematic review of influenza vaccine hesitancy, 2005 – 2016. PLoS One. 2017 . doi:10.1371/journal.pone.0170550.
   Web of Science ®Google Scholar
• Lazarus JV, Wyka K, Rauh L, Rabin K, Ratzan S, Gostin LO, Larson HJ, El-Mohandes A. Hesitant or not? The association of age, gender, and education with potential acceptance of a COVID-19 vaccine: a country-level analysis. J Health Commun. 2020;25:799–807. doi:10.1080/10810730.2020.1868630.
   PubMed Web of Science ®Google Scholar
• Dubé E, Laberge C, Guay M, et al. Vaccine hesitancy: an overview. Human Vacc Immunother. 2013;9(8):1763–73. doi:10.4161/hv.24657.
   PubMed Web of Science ®Google Scholar
• Lin C, Tu P, Beitsch LM. Confidence and receptivity for COVID-19 vaccines: a rapid systematic review. Vaccines (Basel). 2020 ;9:16. doi:10.3390/vaccines9010016.
   PubMed Web of Science ®Google Scholar
• Vieira Rezende RP, Braz AS, Guimarães MFB, Ribeiro SLE, Abreu Vieira RMR, Bica BE, Cruz VA, Libardi Lira Machado KL, Carvalho JS, Monticielo OA, et al. Characteristics associated with COVID-19 vaccine hesitancy: a nationwide survey of 1000 patients with immune-mediated inflammatory diseases. Vaccine. 2021;39:6454–59. doi:10.1016/j.vaccine.2021.09.057.
   PubMed Web of Science ®Google Scholar
• Felten R, Dubois M, Ugarte-Gil MF, et al. Cluster analysis reveals 3 main patterns of behavior towards SARS-CoV-2 vaccination in patients with autoimmune and inflammatory diseases. Rheumatology (Oxford). 2021;keab432. doi:10.1093/rheumatology/keab432.
   PubMedGoogle Scholar
• Sallam M. COVID-19 vaccine hesitancy worldwide: a concise systematic review of vaccine acceptance rates. Vaccines. 2021;9:160. doi:10.3390/vaccines9020160.
   PubMed Web of Science ®Google Scholar
• Argote Tironi P, Barham E, Zuckerman Daly S, Gerez JE, Marshall J, Pocasangre O. Messages that increase COVID-19 vaccine acceptance: evidence from online experiments in six Latin American countries. PLoS One. 2021;16(10):e0259059. doi:https://doi.org/10.1371/journal.pone.0259059.
   PubMed Web of Science ®Google Scholar
• Carnalla M, Basto-Abreu A, Stern D, et al. Acceptance, refusal and hesitancy of Covid-19 vaccination in Mexico: Ensanut 2020 Covid-19. Salud Publica Mex [Internet]. 2021 [citado 23 de noviembre de 2021]. Disponible en;63(5):598–606.
   PubMed Web of Science ®Google Scholar
• Cascini F, Pantovic A, Al-Ajlouni Y, Failla G, Ricciardi W. Attitudes, acceptance and hesitancy among the general population worldwide to receive the COVID-19 vaccines and their contributing factors: a systematic review. EClinicalMedicine. 2021;40:101113. doi:10.1016/j.eclinm.2021.101113.
   PubMedGoogle Scholar
• Fadda M, Albanese E, Suggs LS. When a COVID-19 vaccine is ready, will we all be ready for it? Int J Public Health. 2020;65:711–12. doi:10.1007/s00038-020-01404-4.
   PubMed Web of Science ®Google Scholar
• Healy CM, Pickering LK. How to communicate with vaccine-hesitant parents. Pediatrics. 2011;127(Suppl 1):S127–33. PMID:21502238. doi:10.1542/peds.2010-1722S.
   PubMed Web of Science ®Google Scholar
• Larson HJ, Clarke RM, Jarrett C, Eckersberger E, Levine Z, Schulz WS, Paterson P. Measuring trust in vaccination: a systematic review. Hum Vaccin Immunother. 2018;14:1599–609. doi:10.1080/21645515.2018.1459252.
   PubMed Web of Science ®Google Scholar
• Al-Amer R, Maneze D, Everett B, et al. COVID-19 vaccination intention in the first year of the pandemic: a systematic review. J Clin Nurs. 00:1–25. doi:10.1111/jocn.15951.
   Google Scholar
• Gianfrancesco M, Hyrich KL, Al-Adely S, Carmona L, Danila MI, Gossec L, Izadi Z, Jacobsohn L, Katz P, Lawson-Tovey S, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. Ann Rheum Dis. 2020;79:859–66. doi:10.1136/annrheumdis-2020-217871.
   PubMed Web of Science ®Google Scholar
• Bish A, Yardley L, Nicoll A, Michie S. Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine. 2011;29:6472–84. PMID:21756960. doi:http://dx.doi.org/10.1016/j.vaccine.2011.06.107.
   PubMed Web of Science ®Google Scholar
• Quadri-Sheriff M, Hendrix KS, Downs SM, Sturm LA, Zimet GD, Finnell SME. The role of herd immunity in parents’ decision to vaccinate children: a systematic review. Pediatrics. 2012;130:522–30. PMID:22926181. doi:http://dx.doi.org/10.1542/peds.2012-0140.
   PubMed Web of Science ®Google Scholar
• Graham J, Haidt J, Koleva S, et al. Moral foundations theory: the pragmatic validity of moral pluralism. Adv Exp Soc Psychol. 47:55–130. doi:10.1016/B978-0-12-407236-7.00002-4.
   Web of Science ®Google Scholar
• Graham J, Meindl P, Beall E, Johnson KM, Zhang L. Cultural differences in moral judgment and behavior, across and within societies. Curr Opinion Psychol. 8:125–30. doi:10.1016/j.copsyc.2015.09.007.
   PubMedGoogle Scholar
• Haidt J, Joseph C. Intuitive ethics: How innately prepared intuitions generate culturally variable virtues. Daedalus. 2004;133(4):55–66. doi:10.1162/0011526042365555.
   Web of Science ®Google Scholar
• Leone L, Giacomantonio M, Lauriola M. Moral foundations, worldviews, moral absolutism and belief in conspiracy theories. Int J Psychol. 2017;54:197–204. doi:10.1002/ijop.12459.
   PubMed Web of Science ®Google Scholar
• Chan EY. Moral foundations underlying behavioral compliance during the COVID-19 pandemic. Pers Individ Dif. 2021;171:110463. doi:10.1016/j.paid.2020.110463.
   PubMed Web of Science ®Google Scholar
• Biasio LR. Vaccine hesitancy and health literacy. Hum Vaccin Immunother. 2017;13:701–02. doi:10.1080/21645515.2016.1243633.
   PubMed Web of Science ®Google Scholar
• Dalstra JA, Kunst AE, Borrell C, Breeze E, Cambois E, Costa G, Geurts J, Lahelma E, Van Oyen H, Rasmussen NK, et al. Socioeconomic differences in the prevalence of common chronic diseases: an overview of eight European countries. Int J Epidemiol. 2005;34:316e26. doi:10.1093/ije/dyh386.
   Web of Science ®Google Scholar
• Vilen L, Baldassari AR, Callahan LF. Socioeconomic burden of pain in rheumatic disease. Clin Exp Rheumatol. 2017 ;35(Suppl 107):26–31. Epub 2017 Sep 29. PMID: 28967363.
   PubMedGoogle Scholar
• Luna F. Elucidating the Concept of Vulnerability: Layers Not Labels. Int J Fem Approaches Bioeth. 2009; 2(1):121–39. JSTOR.
   Google Scholar
• Yaqub O, Castle-Clarke S, Sevdalis N, et al. Attitudes to vaccination: a critical review. Soc Sci Med. 2014;112:1–11. doi:10.1016/j.socscimed.2014.04.018.
   PubMed Web of Science ®Google Scholar
• Szilagyi PG, Thomas K, Shah MD, Vizueta N, Cui Y, Vangala S, Kapteyn A. National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020. Jama. 2020;325:396–98. doi:10.1001/jama.2020.26419.
   PubMed Web of Science ®Google Scholar